Target intelligence / Profile preview

Rotavirus VP4 protein (VP4) (VP4)

Target
VP4
Molecular classification
Viral spike protein, Lectin, Structural protein
01

Overview

The Rotavirus VP4 protein, commonly known as the P protein (protease-sensitive), is a key structural component of the rotavirus outer capsid that functions as a viral spike [1, 3]. It is essential for the virus's life cycle, mediating the initial attachment to host cell receptors and subsequent penetration of the cell membrane [3, 4]. For the virus to become infectious, VP4 must undergo proteolytic cleavage by intestinal enzymes into two subunits, VP5* and VP8* [1, 4]. In vaccine development, "P reassortants" are created by combining the VP4 gene from a human rotavirus strain with a bovine rotavirus backbone, a strategy used in the RotaTeq vaccine to provide immunity against common human P genotypes like P[8] [2]. By presenting this specific protein to the immune system, the vaccine induces the production of neutralizing antibodies that prevent the virus from entering host cells, thereby protecting against severe gastroenteritis [2, 3]. This reassortment technique allows for the creation of a live-attenuated virus that expresses human-specific antigens while maintaining the attenuated characteristics of the bovine parent strain [2]. The VP4 protein is a major determinant of viral host range and tissue tropism, making it a primary target for neutralizing immunity [3, 4]. Consequently, monitoring the genetic diversity of the VP4 gene is crucial for assessing vaccine efficacy against emerging rotavirus strains [3].

Other names
P proteinProtease-sensitive proteinSpike protein VP4Outer capsid protein VP4P[8] reassortant
02

Mechanism of action

Induction of neutralizing antibodies that target the VP4 spike protein to inhibit viral attachment and entry into host enterocytes [2, 3].

03

Biological functions

Viral attachmentCell entryMembrane penetrationHost cell recognition
04

Disease associations

Rotavirus infectionGastroenteritis
05

Safety considerations

IntussusceptionVaccine-derived viral sheddingGenetic reassortment with wild-type strains [2, 3]
06

Interacting drugs

RotaTeq

2 more in the full profile.

07

Biomarkers

Anti-VP4 neutralizing antibodiesSerum IgAVP4-specific B cells [2]

Beyond the preview

Go deeper on Rotavirus VP4 protein (VP4) (VP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rotavirus VP4 protein (VP4) (VP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call